These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16160582)

  • 21. The University of California at Los Angeles heart transplantation experience.
    Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A
    Clin Transpl; 2005; ():173-85. PubMed ID: 17424734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recipient age impact on outcome after cardiac transplantation: should it still be considered in organ allocation?
    Sponga S; Deroma L; Sappa R; Piani D; Lechiancole A; Spagna E; Tursi V; Nalli C; Livi U
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):573-9. PubMed ID: 27316658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival beyond 10 years following heart transplantation: The Cleveland Clinic Foundation experience.
    Ozduran V; Yamani MH; Chuang HH; Sipahi I; Cook DJ; Sendrey D; Tong L; Hobbs R; Rincon G; Bott-Silverman C; James K; Taylor DO; Young JB; Navia J; Banbury M; Smedira N; Starling RC
    Transplant Proc; 2005 Dec; 37(10):4509-12. PubMed ID: 16387156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State of the art in paediatric heart transplantation: the Berlin experience.
    Hetzer R; Weng Y; Delmo Walter EM
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):258-67. PubMed ID: 23184909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?
    Groetzner J; Meiser BM; Schirmer J; Koglin J; vScheidt W; Klauss V; Cremer P; Reichenspurner H; Reichart B
    Transplant Proc; 2001; 33(1-2):1461-4. PubMed ID: 11267373
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppression for heart transplantation: where are we now?
    Kobashigawa JA; Patel JK
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):203-12. PubMed ID: 16568129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor-recipient sex mismatch portends poor 10-year outcomes in a single-center experience.
    Kittleson MM; Shemin R; Patel JK; Ardehali A; Kawano M; Davis S; Moriguchi JD; Kobashigawa JA
    J Heart Lung Transplant; 2011 Sep; 30(9):1018-22. PubMed ID: 21550824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretransplant risk factors and causes of death or graft loss after heart transplantation during early infancy. Pediatric Heart Transplant Team, Loma Linda.
    Chinnock RE; Larsen RL; Emery JR; Bailey LL
    Circulation; 1995 Nov; 92(9 Suppl):II206-9. PubMed ID: 7586410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart transplantation in children: clinical outcome during the early postoperative period.
    Azeka E; Auler JO; Marcial MB; Fumagalli F; Ramires JA
    Pediatr Transplant; 2005 Aug; 9(4):491-7. PubMed ID: 16048602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Older Donor Age and Cold Ischemic Time on Long-Term Outcomes of Heart Transplantation.
    Reich HJ; Kobashigawa JA; Aintablian T; Ramzy D; Kittleson MM; Esmailian F
    Tex Heart Inst J; 2018 Feb; 45(1):17-22. PubMed ID: 29556146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up and complications after cardiac transplantation.
    Conrad SA; Chhabra A; Vay D
    J La State Med Soc; 1993 May; 145(5):217-20, 223-5. PubMed ID: 8340685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade.
    Jawitz OK; G Jawitz N; Yuh DD; Bonde P
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1239-45; discussion 1245-6. PubMed ID: 23978472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endomyocardial biopsy in heart transplantation: schedule or event?
    Chi NH; Chou NK; Tsao CI; Huang SC; Wu IH; Yu HY; Chen YS; Wang SS
    Transplant Proc; 2012 May; 44(4):894-6. PubMed ID: 22564577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latest developments in heart transplantation: a review.
    Andrew J; Macdonald P
    Clin Ther; 2015 Oct; 37(10):2234-41. PubMed ID: 26497799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posttransplant Pulmonary Hypertension Is Correlated With Acute Rejection and Death Among Cardiac Transplant Recipients: A Single Center Study.
    Çiftci O; Akgün NA; Yılmaz KC; Karaçağlar E; Aydınalp A; Sezgin A; Müderrisoğlu IH; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):80-84. PubMed ID: 29527998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome.
    Yamani MH; Haji SA; Starling RC; Tuzcu EM; Ratliff NB; Cook DJ; Abdo A; Crowe T; Secic M; McCarthy P; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(6):970-7. PubMed ID: 11897438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative management of heart transplantation patients.
    Vega E; Schroder J; Nicoara A
    Best Pract Res Clin Anaesthesiol; 2017 Jun; 31(2):201-213. PubMed ID: 29110793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival, graft function, and incidence of allograft vasculopathy in heart transplant patients receiving adverse risk profile donor hearts.
    Berg K; Clemmensen TS; Tram EM; Koefoed-Nielsen P; Ilkjaer LB; Poulsen SH; Eiskjaer H
    Clin Transplant; 2018 Aug; 32(8):e13343. PubMed ID: 29974979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.